PATENT CLAIM ANALYSIS

Application Number: 16019941
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "329000"]

Abstract:
The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.

Claim (Index 4):
The method of  claim 3 , wherein the pain is breakthrough pain.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 94.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15478430', '15042999', '11698739', '14448720', '15478499']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8180236856735872
- 35 USC 102 Novelty (BERT): 0.5923230865310131
- Combined Prediction Score: 0.7954536257593299
- Mean Citation Score: 479.24963
- Max Citation Score: 480.19067
- Similarity Product: 469.3488386970394

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test